Table 1.
Subject Demographics and Testing
| DEMOGRAPHICS
|
TESTING
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Subject | Sex | Age at Testing (yr.mo) | Age at Diagnosis (yr.mo) | FSIQ | AED | Session 1 | Session 2 | Session 3 | |||
| Cognitive | EEG | Cognitive | EEG | Cognitive | EEG | ||||||
| 1 | M | 10.0 | 7.10 | 97 | CBZ | Y | N | Y | Y | Y | Y |
| 2 | F | 11.9 | 9.8 | 109 | CBZ | Y | N | Y | Y | Y | Y |
| 3 | M | 11.1 | 9.2 | 105 | VPA | Y | Y | Y | Y | N | N |
| 4 | F | 7.1 | 6.7 | 116 | NONE | Y | Y | Y | Y | Y | Y |
| 5 | F | 11.9 | 8.0 | 107 | CBZ | Y | Y | Y | Y | Y | Y |
| 6 | M | 9.9 | 9.3 | 137 | CBZ | Y | Y | Y | Y | Y | Y |
| Mean ( ± SD) | 10.3 (±1.8) | 8.4 (±1.3) | 111.8 (±13.8) | ||||||||
Abbreviations: AED (anti-epilepsy drug); CBZ (carbamazepine); VPA (valproate); FSIQ (full-scale intelligence quotient); M (male); F (female).